{"id":"https://openalex.org/W1574837249","doi":null,"title":"Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor.","display_name":"Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor.","publication_year":1994,"publication_date":"1994-07-01","ids":{"openalex":"https://openalex.org/W1574837249","mag":"1574837249","pmid":"https://pubmed.ncbi.nlm.nih.gov/8012976"},"language":"en","primary_location":{"id":"pmid:8012976","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8012976","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050120323","display_name":"Willena M. MacKenzie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129902397","display_name":"Dalhousie University","ror":"https://ror.org/01e6qks80","country_code":"CA","type":"education","lineage":["https://openalex.org/I129902397"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"W M MacKenzie","raw_affiliation_strings":["Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada","institution_ids":["https://openalex.org/I129902397"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054931979","display_name":"David W. Hoskin","orcid":"https://orcid.org/0000-0001-9012-0177","observed_orcids":["https://orcid.org/0000-0001-9012-0177"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D W Hoskin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018660886","display_name":"Jonathan Blay","orcid":"https://orcid.org/0000-0003-1169-6966","observed_orcids":["https://orcid.org/0000-0003-1169-6966"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Blay","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.576,"has_fulltext":false,"cited_by_count":84,"citation_normalized_percentile":{"value":0.8219086,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"54","issue":"13","first_page":"3521","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine","display_name":"adenosine","score":0.8859999775886536},{"id":"https://openalex.org/keywords/a3-adenosine-receptor","display_name":"A3 adenosine receptor","score":0.953000009059906},{"id":"https://openalex.org/keywords/adhesion-inhibition","display_name":"adhesion inhibition","score":0.5910000205039978},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.8100000023841858},{"id":"https://openalex.org/keywords/anti-cd3-stimulation","display_name":"anti-CD3 stimulation","score":0.8560000061988831},{"id":"https://openalex.org/keywords/colon-adenocarcinoma","display_name":"colon adenocarcinoma","score":0.8629999756813049},{"id":"https://openalex.org/keywords/tumor-immune-evasion","display_name":"tumor immune evasion","score":0.5820000171661377},{"id":"https://openalex.org/keywords/adenosine-deaminase","display_name":"adenosine deaminase","score":0.6779999732971191},{"id":"https://openalex.org/keywords/coformycin","display_name":"coformycin","score":0.7680000066757202},{"id":"https://openalex.org/keywords/adenosine-receptor-agonists","display_name":"adenosine receptor agonists","score":0.699999988079071},{"id":"https://openalex.org/keywords/purine-nucleosides","display_name":"purine nucleosides","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.828971266746521},{"id":"https://openalex.org/C16587737","wikidata":"https://www.wikidata.org/wiki/Q4682273","display_name":"Adenosine A2B receptor","level":5,"score":0.7363742589950562},{"id":"https://openalex.org/C2909627636","wikidata":"https://www.wikidata.org/wiki/Q356093","display_name":"Adenosine Deaminase Inhibitor","level":4,"score":0.7304989099502563},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.7069392204284668},{"id":"https://openalex.org/C172590197","wikidata":"https://www.wikidata.org/wiki/Q17165723","display_name":"Purinergic signalling","level":5,"score":0.6688225865364075},{"id":"https://openalex.org/C182683403","wikidata":"https://www.wikidata.org/wiki/Q14888579","display_name":"Adenosine A1 receptor","level":5,"score":0.6423555612564087},{"id":"https://openalex.org/C158424129","wikidata":"https://www.wikidata.org/wiki/Q4682275","display_name":"Adenosine A3 receptor","level":5,"score":0.5745805501937866},{"id":"https://openalex.org/C34628245","wikidata":"https://www.wikidata.org/wiki/Q356093","display_name":"Adenosine deaminase","level":3,"score":0.5261616110801697},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.445883184671402},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.40687671303749084},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40455591678619385},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3969549834728241},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3961644470691681},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.371944785118103},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.35321444272994995},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.28376898169517517},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1162949800491333}],"mesh":[{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000230","descriptor_name":"Adenocarcinoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D000241","descriptor_name":"Adenosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D002448","descriptor_name":"Cell Adhesion","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003110","descriptor_name":"Colonic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013805","descriptor_name":"Theobromine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013805","descriptor_name":"Theobromine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013868","descriptor_name":"Thioinosine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D013868","descriptor_name":"Thioinosine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014970","descriptor_name":"Xanthines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017252","descriptor_name":"CD3 Complex","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8012976","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8012976","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:1574837249","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8012976","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W1123722611","https://openalex.org/W1480346895","https://openalex.org/W1488365423","https://openalex.org/W1536628000","https://openalex.org/W1560804531","https://openalex.org/W1575778999","https://openalex.org/W1590792188","https://openalex.org/W1988147130","https://openalex.org/W1997192519","https://openalex.org/W2006876214","https://openalex.org/W2049465772","https://openalex.org/W2050889708","https://openalex.org/W2054120258","https://openalex.org/W2070379407","https://openalex.org/W2076870195","https://openalex.org/W2084839593","https://openalex.org/W2091010390","https://openalex.org/W2091638124","https://openalex.org/W2122624455","https://openalex.org/W2139642525","https://openalex.org/W2141552337","https://openalex.org/W2161004201","https://openalex.org/W2232500106","https://openalex.org/W2255064238","https://openalex.org/W2414743756"],"related_works":["https://openalex.org/W1979942820","https://openalex.org/W2088084884","https://openalex.org/W2075423478","https://openalex.org/W2133498548","https://openalex.org/W2142935448","https://openalex.org/W7097863363","https://openalex.org/W3168470170","https://openalex.org/W2085402245","https://openalex.org/W1710481878","https://openalex.org/W2095909361"],"abstract_inverted_index":{"We":[0,33,265],"have":[1],"investigated":[2],"the":[3,20,30,35,56,59,66,84,90,100,104,131,137,184,187,194,204,225,247,262,280],"hypothesis":[4],"that":[5,144,193,216,267],"adenosine,":[6,69],"a":[7,51,145],"purine":[8],"nucleoside":[9],"produced":[10],"within":[11],"hypoxic":[12],"regions":[13],"of":[14,22,29,37,58,68,79,106,121,155,157,206,227,251,270,282],"solid":[15,286],"tumors,":[16],"may":[17,276],"interfere":[18],"with":[19,182,209,218,234,246],"recognition":[21,250],"tumor":[23,232,253],"cells":[24,28,49,86,229,233],"by":[25,72,111,129,255],"cytolytic":[26],"effector":[27,263],"immune":[31],"system.":[32,53],"measured":[34],"adhesion":[36,71,107,122,226],"murine":[38],"spleen-derived":[39],"anti-CD3-activated":[40],"killer":[41],"(AK)":[42],"lymphocytes":[43],"to":[44,64,74,95,124,221,230,273,288],"syngeneic":[45],"MCA-38":[46,91,231],"colon":[47],"adenocarcinoma":[48],"in":[50,55,279],"model":[52],"Adenosine,":[54,243],"presence":[57],"adenosine":[60,80,96,117,125,158,165,214],"deaminase":[61],"inhibitor":[62],"coformycin":[63],"prevent":[65],"breakdown":[67],"inhibited":[70,224],"up":[73],"60%.":[75],"The":[76,93,119,152],"inhibitory":[77,238],"effect":[78],"was":[81,97,108,126,179],"exerted":[82],"on":[83,89,261],"AK":[85,228,248],"and":[87,159,284],"not":[88,109,127],"targets.":[92],"response":[94],"generated":[98],"at":[99],"cell":[101,249],"surface,":[102],"since":[103],"inhibition":[105,120,205],"abrogated":[110],"S-(4-nitrobenzyl)-6-thioinosine":[112],"or":[113,136,186],"dipyridamole,":[114],"which":[115],"block":[116],"uptake.":[118],"due":[123],"blocked":[128],"either":[130,183],"A1":[132,185],"receptor":[133,139,148,189,198,260],"antagonist":[134,140],"8-cyclopentyl-1,3-dipropylxanthine":[135],"A2":[138,147,188],"3,7-dimethyl-1-propargylxanthine.":[141],"This":[142,175],"suggested":[143],"non-A1,":[146],"might":[149,200],"be":[150,201,277],"involved.":[151],"relative":[153],"order":[154],"potencies":[156],"common":[160],"analogues":[161],"was:":[162],"5'-N-ethylcarboxamidoadenosine":[163],"=":[164,166,172],"(R)-phenylisopropyladenosine":[167],">":[168,170],"N6-cyclopentyladenosine":[169],"2-chloro-N6-cyclopentyladenosine":[171],"2-p-(2-":[173],"carboxyethyl)phenethylamino-5'-N-ethyl-carboxamidoadenosine.":[174],"agonist":[176],"potency":[177,236],"profile":[178],"again":[180],"inconsistent":[181],"subtype":[190,199],"but":[191],"indicated":[192],"recently":[195],"described":[196],"A3":[197,222,259],"responsible":[202],"for":[203],"adhesion.":[207],"Consistent":[208],"this":[210,268],"suggestion,":[211],"aminophenylethyladenosine,":[212],"an":[213,258],"analogue":[215],"binds":[217],"high":[219,235],"affinity":[220],"receptors,":[223],"(50%":[237],"concentration":[239],"approximately":[240],"1":[241],"nM).":[242],"therefore,":[244],"interferes":[245],"colorectal":[252,283],"targets":[254],"acting":[256],"through":[257],"cells.":[264],"suggest":[266],"mechanism":[269],"immunosuppression,":[271],"secondary":[272],"tissue":[274],"hypoxia,":[275],"important":[278],"resistance":[281],"other":[285],"cancers":[287],"immunotherapy.":[289]},"counts_by_year":[{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}